FDA Inspection 1092925 — Dermya, Inc.

Dermya, Inc. — FEI 3014874165

The FDA completed an inspection of Dermya, Inc. on June 5, 2019 in Valley Village, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 5, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Valley Village, CA (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
434321 CFR 211.160(b)(1)Incoming lots - conformance to written specs-